Aethlon Medical, Inc. is a San Diego-based company that specializes in addressing unmet needs in global health through the development of novel immunotherapies. Their groundbreaking technology, the Hemopurifier, is a first-in-class device designed to rapidly deplete cancer-promoting exosomes and circulating viruses in individuals with advanced or metastatic cancer who are unresponsive to or intolerant of standard of care therapy. Recognized as a Breakthrough Device by the United States Food and Drug Administration (FDA), the Hemopurifier offers hope for patients with cancer types where exosomes play a role in disease development or severity, as well as for those with life-threatening viruses that currently lack approved therapies.
Aethlon Medical's mission is to augment the body's natural immune defenses by providing innovative solutions that combat cancer and life-threatening viral infections. With a focus on clinical trials and the advancement of immunotherapy, they strive to improve patient outcomes and address critical gaps in treatment options. Through their dedication to research and development, Aethlon Medical aims to make a significant impact in the field of global health by offering effective therapies that target cancer-promoting exosomes and circulating viruses, ultimately improving the lives of individuals facing these challenging conditions.
Generated from the website